Swapping Aflibercept for Faricimab May Benefit Patients With Nonresponsive Wet AMD
- Posted on: Feb 19 2024
- Leave a response
Patients with neovascular AMD who showed persistent suboptimal responses to aflibercept generally improved after being switched to faricimab, according to this small case study in England.
Source: AAO
Posted in: Uncategorized
